HRP20090470A2 - Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona - Google Patents

Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona Download PDF

Info

Publication number
HRP20090470A2
HRP20090470A2 HR20090470A HRP20090470A HRP20090470A2 HR P20090470 A2 HRP20090470 A2 HR P20090470A2 HR 20090470 A HR20090470 A HR 20090470A HR P20090470 A HRP20090470 A HR P20090470A HR P20090470 A2 HRP20090470 A2 HR P20090470A2
Authority
HR
Croatia
Prior art keywords
oxalate salt
oxalate
compound
drug
salt
Prior art date
Application number
HR20090470A
Other languages
English (en)
Croatian (hr)
Inventor
Neggiani Fabio
Dini Laura
Original Assignee
Abiogen Pharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma S.P.A. filed Critical Abiogen Pharma S.P.A.
Publication of HRP20090470A2 publication Critical patent/HRP20090470A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20090470A 2006-11-02 2007-10-31 Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona HRP20090470A2 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002102A ITMI20062102A1 (it) 2006-11-02 2006-11-02 Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
PCT/IB2007/003292 WO2008053326A1 (en) 2006-11-02 2007-10-31 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Publications (1)

Publication Number Publication Date
HRP20090470A2 true HRP20090470A2 (hr) 2009-11-30

Family

ID=39145485

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20090470A HRP20090470A2 (hr) 2006-11-02 2007-10-31 Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona
HR20090477A HRP20090477A2 (hr) 2006-11-02 2007-10-31 SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20090477A HRP20090477A2 (hr) 2006-11-02 2007-10-31 SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA

Country Status (20)

Country Link
US (2) US20100069451A1 (de)
EP (2) EP2094675B1 (de)
JP (2) JP2010509309A (de)
KR (2) KR20090077014A (de)
CN (2) CN101535281A (de)
AT (2) ATE502021T1 (de)
AU (2) AU2007315832A1 (de)
BR (2) BRPI0718392A2 (de)
CA (2) CA2667513A1 (de)
DE (2) DE602007013801D1 (de)
HR (2) HRP20090470A2 (de)
IL (2) IL198444A0 (de)
IT (1) ITMI20062102A1 (de)
MX (2) MX2009004293A (de)
NO (2) NO20092114L (de)
NZ (2) NZ577978A (de)
RS (2) RS20090389A (de)
RU (2) RU2009120724A (de)
WO (2) WO2008053325A1 (de)
ZA (2) ZA200903618B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112142A1 (de) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Verfahren zur Herstellung eines kristallinen Formverbundstoffs aus 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-on
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2218721A1 (de) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Neuartige Salze von Sitagliptin
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
WO2016123275A1 (en) * 2015-01-30 2016-08-04 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
DE602007013801D1 (de) 2011-05-19
KR20090077014A (ko) 2009-07-13
AU2007315833A1 (en) 2008-05-08
CN101535282A (zh) 2009-09-16
NO20092114L (no) 2009-05-29
JP2010509310A (ja) 2010-03-25
MX2009004294A (es) 2009-05-08
CN101535281A (zh) 2009-09-16
ITMI20062102A1 (it) 2008-05-03
DE602007013278D1 (de) 2011-04-28
WO2008053325A1 (en) 2008-05-08
ZA200903618B (en) 2010-07-28
ZA200903810B (en) 2010-07-28
KR20090082452A (ko) 2009-07-30
WO2008053326A1 (en) 2008-05-08
MX2009004293A (es) 2009-05-08
RU2009120724A (ru) 2010-12-10
EP2094675B1 (de) 2011-04-06
EP2094675A1 (de) 2009-09-02
JP2010509309A (ja) 2010-03-25
EP2094674A1 (de) 2009-09-02
HRP20090477A2 (hr) 2009-11-30
IL198443A0 (en) 2010-02-17
RS20090388A (sr) 2010-12-31
US20100069451A1 (en) 2010-03-18
US20100069450A1 (en) 2010-03-18
IL198444A0 (en) 2010-02-17
NO20092115L (no) 2009-05-29
RS20090389A (sr) 2010-12-31
CA2667515A1 (en) 2008-05-08
ATE504578T1 (de) 2011-04-15
AU2007315832A1 (en) 2008-05-08
NZ577978A (en) 2010-10-29
ATE502021T1 (de) 2011-04-15
EP2094674B1 (de) 2011-03-16
CA2667513A1 (en) 2008-05-08
RU2009120667A (ru) 2010-12-10
NZ577311A (en) 2010-10-29
BRPI0718392A2 (pt) 2013-11-26
BRPI0718391A2 (pt) 2013-11-26

Similar Documents

Publication Publication Date Title
EP1289988B1 (de) 1,4-diazabicyclo[3.2.2]nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
HRP20090470A2 (hr) Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona
EP0446141B1 (de) Imidazo[1,2-c]chinazolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
FR2776660A1 (fr) Diazepino-indoles de phosphodiesterases iv
KR20170061616A (ko) 피마살탄의 신규 염
WO2003044024A1 (fr) Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane, leur preparation et leur application en therapeutique
DE1795022C3 (de) Lysergsäurederivate
LV13556B (en) Pharmaceutical composition comprising a salt of mirtazapine
EP0170549B1 (de) 4,5,6,7-Tetrahydrofuro- oder 1H-Pyrrolo [2,3-c]pyridinderivate, ihre Herstellung und therapeutische Verwendung
EP0082040B1 (de) 3,7a-Diazacyclohepta(j,k)fluorenderivate, ihre Herstellung und ihre therapeutische Verwendung
NL8603236A (nl) Optisch actieve 2-chloor-12-(3-dimethylamino-2-methyl-propyl)-12h-dibenzod,g1,3,6dioxazocinen en een werkwijze voor de bereiding ervan.
CN103288664A (zh) 一种新的bapta衍生物、其制备方法及其医药用途
FR2480602A1 (fr) Hexahydro-pyrimido(1,2-a)azepines 3-substituees a titre de medicaments
LU83644A1 (fr) Nouveau derive de benzanilide doue d'activite anti-arythmique son procede de preparation et composition pharmaceutique le contenant
KR20070094230A (ko) 클로피도그렐 캄파술폰산염 또는 이의 결정다형을 함유하는약학 조성물
FR2517678A1 (fr) Derives oxygenes de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
BE884978A (fr) Nouveaux esters de l'acide benzoique substitue

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20101026

Year of fee payment: 4

OBST Application withdrawn